The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mongkolsapaya, J.
Right arrow Articles by Screaton, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mongkolsapaya, J.
Right arrow Articles by Screaton, G. R.
The Journal of Immunology, 1998, 160: 3-6.
Copyright © 1998 by The American Association of Immunologists

CUTTING EDGE

Cutting Edge: Lymphocyte Inhibitor of TRAIL (TNF-Related Apoptosis-Inducing Ligand): A New Receptor Protecting Lymphocytes from the Death Ligand TRAIL1

Juthathip Mongkolsapaya, Alison E. Cowper, Xiao-Ning Xu, Gwilym Morris, Andrew J. McMichael, John I. Bell and Gavin R. Screaton2

Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom

Apoptosis can be triggered by the engagement of cell surface receptors by their ligands. A growing number of receptors belonging to the TNF receptor family have been identified that contain a conserved cytoplasmic death domain. These include Fas, TNF-R1, lymphocyte-associated receptor of death (LARD), DR4, and TNF-related apoptosis-inducing ligand receptor inducer of cell killing-2 (TRICK2). The latter two are receptors for the cytotoxic ligand TNF-related apoptosis-inducing ligand (TRAIL), and one of the paradoxes raised by the cloning of these molecules was why do most cells not die upon contact with the widely expressed TRAIL molecule? This is a particular problem for lymphocytes that express DR4 and TRICK2 and are in constant circulation through TRAIL-expressing tissues. We have cloned LIT (lymphocyte inhibitor of TRAIL), which lacks a death domain. LIT is expressed predominantly on PBL, where it can competitively inhibit TRAIL-induced apoptosis through DR4/TRICK2, and may function to modulate lymphocyte sensitivity to TRAIL.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
J. Xu, J.-Y. Zhou, W.-Z. Wei, S. Philipsen, and G. S. Wu
Sp1-Mediated TRAIL Induction in Chemosensitization
Cancer Res., August 15, 2008; 68(16): 6718 - 6726.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Xu, J.-Y. Zhou, and G. S. Wu
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Is Required for Tumor Necrosis Factor {alpha}-Mediated Sensitization of Human Breast Cancer Cells to Chemotherapy.
Cancer Res., October 15, 2006; 66(20): 10092 - 10099.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
J. K. Riley, J. M. Heeley, A. H. Wyman, E. L. Schlichting, and K. H. Moley
TRAIL and KILLER Are Expressed and Induce Apoptosis in the Murine Preimplantation Embryo
Biol Reprod, September 1, 2004; 71(3): 871 - 877.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. A. Choi, H. Lei, D. J. Maron, J. M. Wilson, J. Barsoum, D. L. Fraker, W. S. El-Deiry, and F. R. Spitz
Stat1-dependent Induction of Tumor Necrosis Factor-related Apoptosis-inducing Ligand and the Cell-Surface Death Signaling Pathway by Interferon {beta} in Human Cancer Cells
Cancer Res., September 1, 2003; 63(17): 5299 - 5307.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Chen, K. Kandasamy, and R. K. Srivastava
Differential Roles of RelA (p65) and c-Rel Subunits of Nuclear Factor {kappa}B in Tumor Necrosis Factor-related Apoptosis-inducing Ligand Signaling
Cancer Res., March 1, 2003; 63(5): 1059 - 1066.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H.-o. Lee, J. M. Herndon, R. Barreiro, T. S. Griffith, and T. A. Ferguson
TRAIL: A Mechanism of Tumor Surveillance in an Immune Privileged Site
J. Immunol., November 1, 2002; 169(9): 4739 - 4744.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Naka, K. Sugamura, B. L. Hylander, M. B. Widmer, Y. M. Rustum, and E. A. Repasky
Effects of Tumor Necrosis Factor-related Apoptosis-inducing Ligand Alone and in Combination with Chemotherapeutic Agents on Patients' Colon Tumors Grown in SCID Mice
Cancer Res., October 15, 2002; 62(20): 5800 - 5806.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. K. Simon, O. Williams, J. Mongkolsapaya, B. Jin, X. N. Xu, H. Walczak, and G. R. Screaton
Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: Sensitivity of human thymocytes
PNAS, April 12, 2001; (2001) 91100398.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
J. M. Routes, S. Ryan, A. Clase, T. Miura, A. Kuhl, T. A. Potter, and J. L. Cook
Adenovirus E1A Oncogene Expression in Tumor Cells Enhances Killing by TNF-Related Apoptosis-Inducing Ligand (TRAIL)
J. Immunol., October 15, 2000; 165(8): 4522 - 4527.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. D. Zhang, A. V. Franco, T. Nguyen, C. P. Gray, and P. Hersey
Differential Localization and Regulation of Death and Decoy Receptors for TNF-Related Apoptosis-Inducing Ligand (TRAIL) in Human Melanoma Cells
J. Immunol., April 15, 2000; 164(8): 3961 - 3970.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Kim, M. J. Fisher, S.-Q. Xu, and W. S. El-Deiry
Molecular Determinants of Response to TRAIL in Killing of Normal and Cancer Cells
Clin. Cancer Res., February 1, 2000; 6(2): 335 - 346.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
W.-H. Hu, H. Johnson, and H.-B. Shu
Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptors Signal NF-kappa B and JNK Activation and Apoptosis through Distinct Pathways
J. Biol. Chem., October 22, 1999; 274(43): 30603 - 30610.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. D. Bretz, M. Rymaszewski, P. L. Arscott, A. Myc, K. B. Ain, N. W. Thompson, and J. R. Baker Jr.
TRAIL Death Pathway Expression and Induction in Thyroid Follicular Cells
J. Biol. Chem., August 13, 1999; 274(33): 23627 - 23632.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. D. Zhang, A. Franco, K. Myers, C. Gray, T. Nguyen, and P. Hersey
Relation of TNF-related Apoptosis-inducing Ligand (TRAIL) Receptor and FLICE-inhibitory Protein Expression to TRAIL-induced Apoptosis of Melanoma
Cancer Res., June 1, 1999; 59(11): 2747 - 2753.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. S. Wu, T. F. Burns, Y. Zhan, E. S. Alnemri, and W. S. El-Deiry
Molecular Cloning and Functional Analysis of the Mouse Homologue of the KILLER/DR5 Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor
Cancer Res., June 1, 1999; 59(12): 2770 - 2775.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Mori, K. Murakami-Mori, S. Nakamura, A. Ashkenazi, and B. Bonavida
Sensitization of AIDS-Kaposi's Sarcoma Cells to Apo-2 Ligand-Induced Apoptosis by Actinomycin D
J. Immunol., May 1, 1999; 162(9): 5616 - 5623.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. S. Doi, M. W. Marino, T. Takahashi, T. Yoshida, T. Sakakura, L. J. Old, and Y. Obata
Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality
PNAS, March 16, 1999; 96(6): 2994 - 2999.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Kayagaki, N. Yamaguchi, M. Nakayama, A. Kawasaki, H. Akiba, K. Okumura, and H. Yagita
Involvement of TNF-Related Apoptosis-Inducing Ligand in Human CD4+ T Cell-Mediated Cytotoxicity
J. Immunol., March 1, 1999; 162(5): 2639 - 2647.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. S. Griffith, W. A. Chin, G. C. Jackson, D. H. Lynch, and M. Z. Kubin
Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells
J. Immunol., September 15, 1998; 161(6): 2833 - 2840.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
A. Ashkenazi and V. M. Dixit
Death Receptors: Signaling and Modulation
Science, August 28, 1998; 281(5381): 1305 - 1308.
[Abstract] [Full Text]

Home page
 BloodHome page
I. Jeremias, C. Kupatt, B. Baumann, I. Herr, T. Wirth, and K.M. Debatin
Inhibition of Nuclear Factor kappa B Activation Attenuates Apoptosis Resistance in Lymphoid Cells
Blood, June 15, 1998; 91(12): 4624 - 4631.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. A. Kuang, G. E. Diehl, J. Zhang, and A. Winoto
FADD Is Required for DR4- and DR5-mediated Apoptosis. LACK OF TRAIL-INDUCED APOPTOSIS IN FADD-DEFICIENT MOUSE EMBRYONIC FIBROBLASTS
J. Biol. Chem., August 11, 2000; 275(33): 25065 - 25068.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S.-S. Cha, B.-J. Sung, Y.-A Kim, Y.-L. Song, H.-J. Kim, S. Kim, M.-S. Lee, and B.-H. Oh
Crystal Structure of TRAIL-DR5 Complex Identifies a Critical Role of the Unique Frame Insertion in Conferring Recognition Specificity
J. Biol. Chem., September 29, 2000; 275(40): 31171 - 31177.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Harper, S. N. Farrow, A. Kaptein, G. M. Cohen, and M. MacFarlane
Modulation of Tumor Necrosis Factor Apoptosis-inducing Ligand- induced NF-kappa B Activation by Inhibition of Apical Caspases
J. Biol. Chem., September 7, 2001; 276(37): 34743 - 34752.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. K. Simon, O. Williams, J. Mongkolsapaya, B. Jin, X. N. Xu, H. Walczak, and G. R. Screaton
Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: Sensitivity of human thymocytes
PNAS, April 24, 2001; 98(9): 5158 - 5163.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.